In 25 patients with drug-resistant epilepsy, 7-Hz EBS showed higher afterdischarge occurrence than 1-Hz protocols.
This observational study analyzed existing SEEG stimulation data from 25 patients with drug-resistant epilepsy. The analysis compared theta-range EBS at 7 Hz against conventional 1-Hz and 50-Hz stimulation protocols. The primary outcome assessed the occurrence of afterdischarges and clinical signs, with secondary outcomes including seizure induction and electrophysiological responses.
Results indicated that 7-Hz EBS were associated with a higher occurrence of afterdischarges and clinical signs in several temporal structures compared with 1-Hz EBS, with a p-value of 0.014 observed in the parahippocampal epileptogenic zone. In contrast, no systematic significant differences were observed when comparing 7-Hz EBS with 50-Hz protocols. Effects regarding seizure induction were less consistent across the dataset.
No adverse events occurred during the stimulation periods. However, key limitations include the empirical nature of stimulation frequencies and the use of standardized frequencies across patients and brain regions, which can produce false negatives and false positives. These factors may potentially compromise surgical outcomes. The study was not funded by specific entities with reported conflicts of interest.
The practice relevance suggests that theta-range stimulation may provide complementary information to conventional frequencies. Clinicians should consider exploring a broader range of stimulation frequencies while acknowledging that standardized protocols may limit sensitivity in specific anatomical regions.